Nobactra

Company Overview

Snapshot

Founded in January 2013 by Oriella Ben-Zvi, Nobactra operated with 1–10 employees. The company raised a total of $6.7M across 5 funding rounds from 2 investors. Nobactra ceased operations in November 2019.

Business overview

Nobactra developed environmentally friendly formulations designed to control bacterial and fungal diseases within the agriculture sector. The company's core technology leveraged antagonistic bacteria and a powder formulation of essential oils to provide solutions for both plant and poultry health. Its products aimed to offer consistent efficacy across various soil and climate conditions, reduce the likelihood of resistance development, and provide a broad spectrum of activity against diseases like CMM in tomatoes, black root in crucifers, ESCA in grapevines, HLB in citrus, and salmonella and E. coli in poultry. Nobactra operated within the Agriculture & Food Technologies sector, specifically targeting the Ag Tech and Farm Equipment & Treatment markets.

Company Intelligence Q&A

What is Nobactra's primary focus?

Nobactra develops eco-friendly solutions for controlling bacterial and fungal diseases in agriculture, utilizing formulations based on antagonistic bacteria and essential oils.

When was Nobactra founded?

Nobactra was founded in January 2013.

What is the status of Nobactra?

Nobactra is currently non-active, having ceased operations in November 2019.

What was Nobactra's last funding round?

Nobactra's last funding round was a $2M Series A.

What types of diseases did Nobactra's solutions target?

Nobactra's solutions targeted diseases in plants such as CMM, black root, ESCA, and HLB, and in poultry, they demonstrated efficacy against salmonella and E. coli.